Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) will report its next earnings on Feb 21 – Feb 27 (Est.). The company reported the earnings of $-0.58/Share in the last quarter where the estimated EPS by analysts was $-0.5/share. The difference between the expected and actual EPS was $-0.08/share, which represents an Earnings surprise of -16%.
In case of Revenue Estimates, 5 analysts have provided their consensus Average Revenue Estimates for Tetraphase Pharmaceuticals, Inc. as 1.58 Million. According to these analysts, the Low Revenue Estimate for Tetraphase Pharmaceuticals, Inc. is 1.2 Million and the High Revenue Estimate is 2 Million. The company had Year Ago Sales of 2.47 Million.
Some buy side analysts are also providing their Analysis on Tetraphase Pharmaceuticals, Inc., where 0 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 6 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
When it comes to the Analysis of a Stock, Price Target plays a vital role. 4 Analysts reported that the Price Target for Tetraphase Pharmaceuticals, Inc. might touch $14 high while the Average Price Target and Low price Target is $7.25 and $4 respectively.
To analyze a stock, one should look for Upgrades and Downgrades of a stock. Tetraphase Pharmaceuticals, Inc. got Downgrade on 13-May-16 where investment firm Gabelli & Co Downgrade the stock from Buy to Hold.
Tetraphase Pharmaceuticals, Inc. closed its last trading session at $4.13 with the gain of 8.96%. The Market Capitalization of the company stands at 166.05 Million. The Company has 52-week high of $11.81 and 52-week low of $3.11. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 18.7% where SMA50 and SMA200 are 19.91% and 7.62% respectively. The Company Touched its 52-Week High on Dec 2, 2015 and 52-Week Low on Nov 4, 2016.
The Relative Volume of the company is 3.7 and Average Volume (3 months) is 318.19 million. Tetraphase Pharmaceuticals, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.
The company shows its Return on Assets (ROA) value of -37.7%. The Return on Equity (ROE) value stands at -39.9%. While it’s Return on Investment (ROI) value is -40.7%.
While looking at the Stock’s Performance, Tetraphase Pharmaceuticals, Inc. currently shows a Weekly Performance of 13.35%, where Monthly Performance is 26.76%, Quarterly performance is 15.98%, 6 Months performance is 0.9% and yearly performance percentage is -58.06%. Year to Date performance value (YTD perf) value is -55.13%. The Stock currently has a Weekly Volatility of 7.07% and Monthly Volatility of 6.49%.